世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036743

タンパク質治療薬の世界市場規模調査・予測:製品別、用途別、および地域別の分析(2023年〜2030年)

Bizwit Research & Consulting LLP

Global Protein Therapeutics Market Size Study & Forecast, by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Application (Metabolic Disorders, Immunologic Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others), and Regional Analysis, 2023-2030

発刊日 2023/10/20

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000036743

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のタンパク質治療薬市場は、2022年に約3,253億5,000万米ドルと評価され、2023年から2030年の予測期間にわたって7.1%を超える健全な成長率で成長すると予想されています。 ンパク質治療薬とは、タンパク質またはペプチドに基づく治療薬のクラスを指します。タンパク質は、免疫機能、代謝、細胞シグナル伝達などのさまざまな生物学的機能にとって重要な実質的な分子です。これらの治療用化合物は、受容体、酵素、シグナル伝達分子などの特定の身体標的と相互作用することにより、病気、障害、病状を治療することを目的としています。有利な規制環境、高齢者人口の増加、生物製剤部門の発展と医療費の増加が、世界中の市場需要を刺激する重要な要因となっています。

さらに、がん、糖尿病、心血管障害、自己免疫疾患などの慢性疾患の有病率の上昇により、推定期間中にタンパク質治療薬の需要が高まっています。国立がん研究所によると、2018年のがん患者数は1,810万人と推定され、2040年までに2,950万人に達すると予測されています。さらに、国際糖尿病連盟(IDF)は、2021年には約5億3,700万人の成人(20〜79歳)が糖尿病を抱えて暮らしていると報告した。また、糖尿病を抱えて生きる人の総数は、2030 年までに 6 億 4,300 万人、2045 年までに 7 億 8,300 万人に増加すると予想されています。したがって、これらの疾患には一般に、タンパク質治療薬のような、標的を絞った個別の治療アプローチが必要であり、それがひいては糖尿病市場の成長をかなりの割合で促進します。さらに、バイオテクノロジーやタンパク質工学の進歩、プロテオミクス研究の成長により、今後数年間にわたってさまざまな有利な機会がもたらされます。ただし、必要な高い生産コストと複雑な製造プロセスが、2023年から2030年の予測期間を通じて市場の成長に課題をもたらしています。

世界のタンパク質治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、バイオテクノロジーのますますの進歩、研究開発活動への資金の増加、およびこの地域の主要企業の存在により、2022 年の市場を支配しました 一方、アジア太平洋地域は、予測期間中に最も高い CAGR で成長すると予想されます。高齢者人口の急速な増加、タンパク質治療薬に対する患者の意識の高まり、慢性疾患の有病率の増加により、この地域全体の市場需要が大幅に増加しています。

調査範囲

  • 調査企業
    ➣ Novo Nordisk AS
    ➣ Baxter International Inc.
    ➣ Amgen Inc.
    ➣ Merck and Co., Inc.
    ➣ Sanofi S.A.
    ➣ Eli Lilly And Company
    ➣ Abbott Laboratories
    ➣ Pfizer Inc.
    ➣ Johnson and Johnson (Janssen Pharmaceuticals)
    ➣ F. Hoffmann La Roche Ltd
  • 調査対象年
    ➣ 実績データ - 2020 - 2021
    ➣ 推定基準年 - 2022
    ➣ 予測期間 - 2023-2030

この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。

このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。

  • 市場セグメント
    ➣ 製品別
      ◇ モノクローナル抗体
      ◇ インスリン
      ◇ 融合タンパク質
      ◇ エリスロポエチン
      ◇ インターフェロン
      ◇ ヒト成長ホルモン
      ◇ 卵胞刺激ホルモン
    ➣ 用途別
      ◇ 代謝障害
      ◇ 免疫疾患
      ◇ がん
      ◇ ホルモン障害
      ◇ 遺伝性疾患
      ◇ その他
    ➣ 地域別
       ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
       ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
       ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
       ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ◇ 中東・アフリカ
       ✓ サウジアラビア
       ✓ 南アフリカ
       ✓ その他の中東・アフリカ

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Protein Therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Protein Therapeutics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Protein Therapeutics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Protein Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Protein Therapeutics Market Dynamics
3.1. Protein Therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Development of the biologics sector
3.1.1.2. Rising prevalence of chronic diseases
3.1.2. Market Challenges
3.1.2.1. High production costs required
3.1.2.2. Complex manufacturing processes
3.1.3. Market Opportunities
3.1.3.1. Rising advancements in biotechnology and protein engineering
3.1.3.2. Growth in proteomic research

Chapter 4. Global Protein Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Protein Therapeutics Market, by Product
5.1. Market Snapshot
5.2. Global Protein Therapeutics Market by Product, Performance - Potential Analysis
5.3. Global Protein Therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Protein Therapeutics Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Insulin
5.4.3. Fusion Protein
5.4.4. Erythropoietin
5.4.5. Interferon
5.4.6. Human Growth Hormone
5.4.7. Follicle Stimulating Hormone

Chapter 6. Global Protein Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global Protein Therapeutics Market by Application, Performance - Potential Analysis
6.3. Global Protein Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Protein Therapeutics Market, Sub Segment Analysis
6.4.1. Metabolic Disorders
6.4.2. Immunologic Disorders
6.4.3. Cancer
6.4.4. Hormonal Disorders
6.4.5. Genetic Disorders
6.4.6. Others

Chapter 7. Global Protein Therapeutics Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Protein Therapeutics Market, Regional Market Snapshot
7.4. North America Protein Therapeutics Market
7.4.1. U.S. Protein Therapeutics Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Protein Therapeutics Market
7.5. Europe Protein Therapeutics Market Snapshot
7.5.1. U.K. Protein Therapeutics Market
7.5.2. Germany Protein Therapeutics Market
7.5.3. France Protein Therapeutics Market
7.5.4. Spain Protein Therapeutics Market
7.5.5. Italy Protein Therapeutics Market
7.5.6. Rest of Europe Protein Therapeutics Market
7.6. Asia-Pacific Protein Therapeutics Market Snapshot
7.6.1. China Protein Therapeutics Market
7.6.2. India Protein Therapeutics Market
7.6.3. Japan Protein Therapeutics Market
7.6.4. Australia Protein Therapeutics Market
7.6.5. South Korea Protein Therapeutics Market
7.6.6. Rest of Asia Pacific Protein Therapeutics Market
7.7. Latin America Protein Therapeutics Market Snapshot
7.7.1. Brazil Protein Therapeutics Market
7.7.2. Mexico Protein Therapeutics Market
7.8. Middle East & Africa Protein Therapeutics Market
7.8.1. Saudi Arabia Protein Therapeutics Market
7.8.2. South Africa Protein Therapeutics Market
7.8.3. Rest of Middle East & Africa Protein Therapeutics Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novo Nordisk AS
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Baxter International Inc.
8.3.3. Amgen Inc.
8.3.4. Merck and Co., Inc.
8.3.5. Sanofi S.A.
8.3.6. Eli Lilly And Company
8.3.7. Abbott Laboratories
8.3.8. Pfizer Inc.
8.3.9. Johnson and Johnson (Janssen Pharmaceuticals)
8.3.10. F. Hoffmann La Roche Ltd

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Protein Therapeutics Market, report scope
TABLE 2. Global Protein Therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Protein Therapeutics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Protein Therapeutics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Protein Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Protein Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

List of figures
FIG 1. Global Protein Therapeutics Market, research methodology
FIG 2. Global Protein Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Protein Therapeutics Market, key trends 2022
FIG 5. Global Protein Therapeutics Market, growth prospects 2023-2030
FIG 6. Global Protein Therapeutics Market, porters 5 force model
FIG 7. Global Protein Therapeutics Market, pest analysis
FIG 8. Global Protein Therapeutics Market, value chain analysis
FIG 9. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Protein Therapeutics Market, regional snapshot 2020 & 2030
FIG 15. North America Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Protein Therapeutics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Protein Therapeutics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000036743

TOP